BMS Forgoes Thalassemia Label Expansion Revenues For Rebozyl

Withdraws Reblozyl sBLA

 
• By Ayisha Sharma
BMS Is Doing A U-Turn On Its Expansion Plans For Reblozyl • Source: Shutterstock

More from Business

More from Scrip